Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Flamini JR"'
Autor:
Sankar R; Departments of Neurology and Pediatrics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA; UCLA Mattel Children's Hospital, Los Angeles, CA, USA. Electronic address: RSankar@ucla.edu., Chez M; Sutter Health, Roseville, CA, USA; California Northstate University School of Medicine, Elk Grove, CA, USA., Pina-Garza JE; The Children's Hospital at TriStar Centennial, Nashville, TN, USA., Dixon-Salazar T; Lennox-Gastaut Syndrome Foundation, San Diego, CA, USA., Flamini JR; PANDA Neurology, Atlanta, GA, USA., Hyslop A; Stanford University School of Medicine, Palo Alto, CA, USA., McGoldrick P; Boston Children's Health Physicians, Valhalla, NY, USA; Maria Fareri Children's Hospital, Valhalla, NY, USA; New York Medical College, Valhalla, NY, USA., Millichap JJ; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Resnick T; Nicklaus Children's Hospital, Miami, FL, USA., Rho JM; Departments of Neurosciences, Pediatrics & Pharmacology, University of California San Diego and Rady Children's Hospital, San Diego, CA, USA., Wolf S; Boston Children's Health Physicians, Valhalla, NY, USA; Maria Fareri Children's Hospital, Valhalla, NY, USA; New York Medical College, Valhalla, NY, USA.
Publikováno v:
Seizure [Seizure] 2023 Aug; Vol. 110, pp. 42-57. Date of Electronic Publication: 2023 May 25.
Autor:
Park YD; Augusta University, Augusta, GA, United States. Electronic address: YPARK@augusta.edu., Linder DF; Augusta University, Augusta, GA, United States. Electronic address: dlinder@augusta.edu., Pope J; Augusta University, Augusta, GA, United States. Electronic address: jampope@umd.edu., Flamini JR; Panda Neurology, Atlanta, GA, United States. Electronic address: rflamini@comcast.net., Moretz K; Memorial Health University Medical Center, Savannah, GA, United States., Diamond MP; Augusta University, Augusta, GA, United States. Electronic address: midiamond@augusta.edu., Long SA; Augusta University, Augusta, GA, United States. Electronic address: salong@augusta.edu.
Publikováno v:
Epilepsy & behavior : E&B [Epilepsy Behav] 2020 Nov; Vol. 112, pp. 107474. Date of Electronic Publication: 2020 Sep 28.
Autor:
Yang, Lu1 (AUTHOR), Liu, Yuhang1 (AUTHOR), Deng, Yu1 (AUTHOR), Peng, Xiaoling2 (AUTHOR), Hu, Qiao1 (AUTHOR), Jiang, Li1 (AUTHOR), Hu, Yue1 (AUTHOR) huyue915@163.com
Publikováno v:
CNS Neuroscience & Therapeutics. Aug2024, Vol. 30 Issue 8, p1-10. 10p.
Autor:
Farkas V; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia. farkas.viktor@med.semmelweis-univ.hu., Steinborn B; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Flamini JR; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Zhang Y; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Yuen N; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Borghs S; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Bozorg A; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Daniels T; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Martin P; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Carney HC; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Dimova S; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia., Scheffer IE; From the First Department of Pediatrics (V.F.), Semmelweis University, Budapest, Hungary; Department of Developmental Neurology (B.S.), Poznań University of Medical Sciences, Poland; PANDA Neurology (J.R.F.), Atlanta, GA; UCB Pharma (Y.Z., N.Y., A.B., T.D.), Raleigh, NC; UCB Pharma (S.B.), Slough, UK; UCB Pharma (P.M.), Braine-l'Alleud, Belgium; Evidence Scientific Solutions (H.C.C.), Horsham, UK; UCB Pharma (S.D.), Brussels, Belgium; and Austin Health (I.E.S.), Florey and Murdoch Children's Research Institute, University of Melbourne, Australia.
Publikováno v:
Neurology [Neurology] 2019 Sep 17; Vol. 93 (12), pp. e1212-e1226. Date of Electronic Publication: 2019 Aug 28.
Autor:
Woods, Megan1, Phelps, Stephanie J.2,3 sphelps44@icloud.com, Christensen, Michael L.1,2, Meibohm, Bernd4, Wheless, James W.1,3
Publikováno v:
Journal of Pediatric Pharmacology & Therapeutics. 2024, Vol. 29 Issue 5, p514-524. 11p.
Autor:
Makedonska, Iryna1 (AUTHOR), Ng, Yu‐Tze2 (AUTHOR), Beller, Cynthia3 (AUTHOR), Bozorg, Ali3 (AUTHOR), Csikós, János4 (AUTHOR), McClung, Carrie3 (AUTHOR), Moeltgen, Holger4 (AUTHOR), Farkas, Mark Kristof5 (AUTHOR) kristofm.farkas@gmail.com, da Silva Pereira Almeida, Conceição Campanário (AUTHOR), Altmann, Anna (AUTHOR), Arefieva, Elena (AUTHOR), Arnold, Susan (AUTHOR), Axente, Mihaela (AUTHOR), Baglietto, Maria Giuseppina (AUTHOR), Bakhtadze, Sophio (AUTHOR), Battaglia, Domenica Immacolata (AUTHOR), Belova, Liudmila (AUTHOR), Berényi, Marianne (AUTHOR), Calcii, Cornelia (AUTHOR), Cao, Dezhi (AUTHOR)
Publikováno v:
Annals of Clinical & Translational Neurology. Mar2024, Vol. 11 Issue 3, p768-779. 12p.
Autor:
Bozorg, Ali1 (AUTHOR) abozorg57@gmail.com, Beller, Cynthia1 (AUTHOR), Jensen, Lori1 (AUTHOR), Arzimanoglou, Alexis2,3 (AUTHOR), Chiron, Catherine4 (AUTHOR), Dlugos, Dennis5 (AUTHOR), Gaitanis, John6 (AUTHOR), Wheless, James W.7 (AUTHOR), McClung, Carrie1 (AUTHOR)
Publikováno v:
Annals of Clinical & Translational Neurology. Mar2024, Vol. 11 Issue 3, p780-790. 11p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Franz DN; Department of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States of America., Belousova E; Department of Pediatrics, Research and Clinical Institute of Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russia., Sparagana S; Department of Neurology, Texas Scottish Rite Hospital for Children, Dallas, Texas, United States of America., Bebin EM; Department of Neurology, University of Alabama School of Medicine, Birmingham, Alabama, United States of America., Frost MD; Department of Neurology, Minnesota Epilepsy Group, St. Paul, Minnesota, United States of America., Kuperman R; Department of Neurology, Children's Hospital and Research Center, Oakland, California, United States of America., Witt O; Department of Oncology, University of Heidelberg Medical Center and German Cancer Research Center, Heidelberg, Germany., Kohrman MH; Department of Neurology, University of Chicago, Chicago, Illinois, United States of America., Flamini JR; Department of Neurology, Children's Healthcare of Atlanta, Atlanta, Georgia, United States of America., Wu JY; Department of Neurology, Mattel Children's Hospital at the University of California Los Angeles, Los Angeles, California, United States of America., Curatolo P; Department of Neurology, University of Rome Tor Vergata, Rome, Italy., de Vries PJ; Department of Psychiatry and Mental Health, Division of Child & Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa., Berkowitz N; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, United States of America., Niolat J; Department of Oncology, Novartis Pharmaceuticals S.A.S., Rueil-Malmaison, France., Jóźwiak S; Department of Pediatric Neurology, Medical University of Warsaw, Warsaw, Poland.
Publikováno v:
PloS one [PLoS One] 2016 Jun 28; Vol. 11 (6), pp. e0158476. Date of Electronic Publication: 2016 Jun 28 (Print Publication: 2016).
Autor:
Franz DN; Department of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Electronic address: david.franz@cchmc.org., Belousova E; Moscow Research Institute of Pediatrics and Pediatric Surgery, Moscow, Russia., Sparagana S; Department of Neurology, Texas Scottish Rite Hospital for Children, Dallas, TX, USA., Bebin EM; Department of Neurology, University of Alabama School of Medicine, Birmingham, AL, USA., Frost M; Department of Neurology, Minnesota Epilepsy Group, St Paul, MN, USA., Kuperman R; Department of Neurology, Children's Hospital and Research Center, Oakland, CA, USA., Witt O; Department of Oncology, University of Heidelberg Medical Center and German Cancer Research Center, Heidelberg, Germany., Kohrman MH; Department of Neurology, University of Chicago, Chicago, IL, USA., Flamini JR; Department of Neurology, Children's Healthcare of Atlanta, Atlanta, GA, USA., Wu JY; Department of Neurology, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, USA., Curatolo P; Department of Neurology, University of Rome Tor Vergata, Rome, Italy., de Vries PJ; Department of Psychiatry and Mental Health, Division of Child and Adolescent Psychiatry, University of Cape Town, South Africa., Berkowitz N; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Anak O; Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Niolat J; Novartis Pharmaceuticals SAS, Rueil-Malmaison, France., Jozwiak S; Department of Neurology, Children's Memorial Health Institute, Al Dzieci Polskich 20, Warsaw, Poland.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2014 Dec; Vol. 15 (13), pp. 1513-1520. Date of Electronic Publication: 2014 Nov 10.